Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Possible implication of Mdm2 as a prognostic marker in invasive laryngeal carcinoma (2012)

  • Authors:
  • USP affiliated authors: DONADI, EDUARDO ANTONIO - FMRP ; SOARES, EDSON GARCIA - FMRP
  • USP Schools: FMRP; FMRP
  • DOI: 10.1007/s00405-012-1937-3
  • Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO; LARINGE; PAPILLOMAVIRUS; CARCINOMA DE CÉLULAS ESCAMOSAS
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s00405-012-1937-3 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: European Archives of Oto-Rhino-Laryngology

    ISSN: 0937-4477

    Citescore - 2017: 1.54

    SJR - 2017: 0.8

    SNIP - 2017: 1.061


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP2305335pcd 2305335 estantes deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      HASSUMI-FUKUSAWA, Marcela K.; MIRANDA-CAMARGO, Fabiana A.0; GUIMARÃES, Márcia C. M.; et al. Possible implication of Mdm2 as a prognostic marker in invasive laryngeal carcinoma. European Archives of Otorhinolaryngology, Heidelberg, v. 269, n. 7, p. 1795-1804, 2012. Disponível em: < http://dx.doi.org/10.1007/s00405-012-1937-3 > DOI: 10.1007/s00405-012-1937-3.
    • APA

      Hassumi-Fukusawa, M. K., Miranda-Camargo, F. A. 0, Guimarães, M. C. M., Simões, R. T., Donadi, E. A., Soares, C. P., & Soares, E. G. (2012). Possible implication of Mdm2 as a prognostic marker in invasive laryngeal carcinoma. European Archives of Otorhinolaryngology, 269( 7), 1795-1804. doi:10.1007/s00405-012-1937-3
    • NLM

      Hassumi-Fukusawa MK, Miranda-Camargo FA0, Guimarães MCM, Simões RT, Donadi EA, Soares CP, Soares EG. Possible implication of Mdm2 as a prognostic marker in invasive laryngeal carcinoma [Internet]. European Archives of Otorhinolaryngology. 2012 ; 269( 7): 1795-1804.Available from: http://dx.doi.org/10.1007/s00405-012-1937-3
    • Vancouver

      Hassumi-Fukusawa MK, Miranda-Camargo FA0, Guimarães MCM, Simões RT, Donadi EA, Soares CP, Soares EG. Possible implication of Mdm2 as a prognostic marker in invasive laryngeal carcinoma [Internet]. European Archives of Otorhinolaryngology. 2012 ; 269( 7): 1795-1804.Available from: http://dx.doi.org/10.1007/s00405-012-1937-3

    Referências citadas na obra
    Agarwal S, Mathur M, Srivastava A, Ralhan R (1999) Mdm2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications. Oral Oncol 35:209–216
    Ambrosch P, Ruschenburg I (2000) p53 and MDM2 protein expression in squamous cell carcinoma and neighboring dysplasia from the upper aerodigestive tract. Anticancer Res 20(5A):3151–3155
    Anantharaman D, Marron M, Lagiou P, Samoli E, Ahrens W, Pohlabeln H, Slamova A, Schejbalova M, Merletti F, Richiardi L, Kjaerheim K, Castellsague X, Agudo A, Talamini R, Barzan L, Macfarlane TV, Tickle M, Simonato L, Canova C, Conway DI, McKinney PA, Thomson P, Znaor A, Healy CM, McCartan BE, Hashibe M, Brennan P, Macfarlane GJ (2011) Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer. Oral Oncol 47(8):725–731
    Bettini JS, Soares EG, Duarte G, Simões RT, Simões AL (2003) PCR diagnosis of HPV in cervical biopsies of CIN and invasive neoplasia formerly diagnosed as HPV negative. Acta Cytol 47(4):545–549
    Bloom J, Pagano M (2003) Deregulated degradation of the CDK inhibitors and malignant transformation. Semin Cancer Biol 13:41–47
    Camus S, Higgins M, Lane DP, Lain S (2003) Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6. FEBS Lett 536:220–224
    Catarruza MS, Maisonneuve P, Boyke P (1996) Epidemiology of laryngeal cancer. Oral Oncol Eur J Cancer 32B:293–305
    Chen Y, Jin Y, Shich D, Tsai S, Wu L (2002) Molecular characterization of angiogenic properties of human oral squamous cell carcinoma cells. Oral Oncol 38:699–705
    Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S (2003) Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88:63–73
    de Oliveira DE, Bacchi MM, Macarenco RS, Tagliarini JV, Cordeiro RC, Bacchi CE (2006) Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma. Am J Clin Pathol 126:284–293
    Deb SP (2003) Cell cycle regulatory functions of the human oncoprotein MDM2. Mol Cancer Res 1(14):1009–1016
    Depuydt CE, Boulet GAV, Horvath CAJ, Benoy IH, Vereecken AJ, Bogers JJ (2007) Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med 2007(11):881–891
    Fan GK, Fujieda S, Sunaga H, Tsuzuki H, Ito N, Saito H (1999) Expression of protein p27 is associated with progression and prognosis in laryngeal cancer. Laryngoscope 109(5):815–820
    Fernandez-Acenero MJ, Larach F, Aramendi T, Ortega P (2008) Possible prognostic role of p53 expression in laryngeal squamous cell carcinoma of non-smokers, non-alcoholic patients. Acta Otolaryngol 128:1385–1388
    Fillies T, Weltering M, Bandt B, Van Diest JP, Werkmeister R, Joss U, Buerger H (2007) Cell cycle regulating proteins p21 and p27 in prognosis of oral squamous cell carcinomas. Oncol Rep 17:355–359
    García Lozano MC, Orradre Romero JL, Martínez Alvarez A, Sáez del Castillo AI, Piris Pinilla MA (2004) Pronostic value of the MDM-2 protein expression in the larynx cancer. An Otorrinolaringol Ibero Am 31(6):571–582
    Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92(9):709–720
    Girod SC, Cesarz D, Fischer U, Krueger GR (1995) Detection of p53 and MDM2 protein expression in head and neck carcinogenesis. Anticancer Res 15(4):1453–1457
    Goiato MC, Fernandes AUR, Santos DM, Neto SC (2006) Perfil de pacientes acometidos por câncer de laringe atendido no centro de oncologia bucal—UNESP. Revista Odonto Ciência (Journal of Dental Science) 21:3–8
    Gorgoulis VG, Zacharatos P, Kotsinas A et al (1999) Human papilloma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum Pathol 30:274–283
    Gungor A, Cincik H, Baloglu H, Cekin E, Dogru S, Dursun E (2007) Human papilloma virus prevalence in laryngeal squamous cell carcinoma. J Laryngol Otol 121:772–774
    Hardisson D (2003) Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 260(9):502–508
    Higashiyama M, Doi O, Kodama K, Yokouchi H, Kasugai T, Ishiguro S (2001) MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favorable prognostic marker in patients without p53 protein accumulation. Br J Cancer 75:1302–1308
    Hirai T, Hayashi K, Takumida M, Ueda T, Hirakawa K, Yajin K (2003) Reduced expression of p27 is correlated with progress in precancerous lesions of the larynx. Auris Nasus Larynx 30:163–168
    Islami F, Tramacere I, Rota M, Bagnardi V, Fedirko V, Scotti L, Garavello W, Jenab M, Corrao G, Straif K, Negri E, Boffetta P, La Vecchia C (2010) Alcohol drinking and laryngeal cancer: overall and dose-risk relation—a systematic review and meta-analysis. Oral Oncol 11:802–810
    Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, ward E, Feuer EJ (2004) Cancer statistics. Cancer J Clin 54:8–29
    Joerger AC, Fersht AR (2008) Structural biology of the tumor suppressor p53. Annu Rev Biochem 77:557–582
    Kazkayasi M, Hücümeno˘glu S, Siriner GI, Hücümeno˘glu M (2001) Over-expression of p53 and c-erbB-2 oncoproteins in laryngeal carcinoma. Eur Arch Otorhinolaryngol 258:329–335
    Khoo MLC, Brasley NJP, Ezzat S, Freeeman JL, Asa SL (2002) Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma. J Clin Endocrinol Metab 87:1814–1818
    Kim YT, Choia EK, Chob NH, Koc JH, Yanb WI, Kima JW, Lee SH (2000) Expression of cyclin E and p27KIP1 in cervical carcinoma. Cancer Lett 153:41–50
    Klatka J (2001) Prognostic value of the expression of p53 and bcl-2 in patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol 258:537–541
    Korkmaz H, Du W, Yoo GH, Enamorado II, Lin HS, Adsy V, Kewson D, Ensley JF, Shibuya TY, Jabobs JR, Kim H (2005) Prognostic significance of G1 cell-cycle inhibitors in early laryngeal cancer. Am J Otolaryngol-Head Neck Med Surg 26:77–82
    Koskinen WJ, Brøndbo K, Mellin Dahlstrand H, Luostarinen T, Hakulinen T, Leivo I, Molijn A et al (2007) Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study. J Cancer Res Clin Oncol 133:673–678
    Kudo Y, Katajima S, Ogawa I, Miyauchi M, Takata T (2005) Down regulation of Cdk inhibitor p27 in oral squamous cell carcinoma. Oral Oncol 41:105–116
    Kuo MYP, Hsu HJ, Kok SH, Kuo RC, Yang H, Hanh LJ, Chiang CP (2002) Prognostic role of p27 kip1 expression in oral squamous cell carcinoma in Taiwan. Oral Oncol 38:172–178
    Lacy ER, Filippov I, Lewis WS, Otieno S, Xiao L, Weiss S, Hengst L, Kriwacki RW (2004) p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding. Nat Struct Mol Biol 11:358–364
    Lindeberg H, Krogdahl A (1999) Laryngeal cancer and human papillomavirus: HPV is absent in the majority of laryngeal carcinomas. Cancer Lett 146:9–13
    Ma XL, Ueno K, Pan ZM, Hi SZ, Ohyama M, Eizuru Y (1998) Human papillomavirus DNA sequences and p53 over-expression in laryngeal squamous cell carcinomas in Northeast China. J Med Virol 54:186–191
    Manfredi JJ (2010) The Mdm2–p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor. Genes Dev 24(15):1580–1589
    Matsumura T, Yoshihama Y, Kimura T, Shintani S, Alcalde RE (1996) p53 and MDM2 expression in oral squamous cell carcinoma. Oncology 53(4):308–312
    Micozkadioğlu D, Unal M, Pata YS, Baştürk M, Cinel L (2008) Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma. Med Sci Monit 14(6):CR299–CR304
    Miranda FA, Hassumi MK, Guimarães MCM, Simões RT, Silva TG, Lira RC, Rocha AM, Mendes CT, Donadi EA, Soares CP, Soares EG (2009) Galectin-3 overexpression in invasive laryngeal carcinoma assessed by computer-assisted analysis. Histochem Cytochem 57(7):665–673
    Morshed K, Korobowicz E, Szymanski M, Skomra D, Goabek W (2005) Immunohistochemical demonstration of multiple HPV types in laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 262:917–920
    Morshed K, Polz-Dacewicz M, Szymanski M, Polz D (2008) Short-fragment PCR assay for highly sensitive broad-spectrum detection of human papillomaviruses in laryngeal squamous cell carcinoma and normal mucosa: clinico-pathological evaluation. Eur Arch Otorhinolaryngol 265(Suppl 1):S89–S96
    Nakashima T, Wang XF, Masuda M, Inokuchi A, Komiyama S (1999) Overexpression of p53 nuclear protein in premalignant and malignant laryngeal lesions. Eur Arch Otorhinolaryngol 256:56–59
    Narayana A, Vaughan AT, Gunaratne S, Kathuria S, Walter SA, Reddy SP (1998) Is p53 an independent prognostic factor in patients with laryngeal carcinoma? Cancer 82(2):286–291
    Nylander K, Dabelsteen E, Hall PA (2000) The p53 molecule and its prognostic role in squamous cell carcinoma of the head and neck. J Oral Pathol Med 29:413–425
    Pelucchi C, Gallus S, Garavello W, Bosetti C, La Vecchia C (2008) Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. Eur J Cancer Prev 17(4):340–344
    Peschos D, Tsanou E, Stefanou D, Damala C, Vougiouklakis T, Mitselou A, Agnantis NJ (2004) Expression of cyclin-dependent kinases inhibitors p21(WAF1) and p27(KIP1) in benign, premalignant and malignant laryngeal lesions: correlation with cell cycle regulatory proteins. In Vivo 18(6):719–724
    Pignataro L, Sambataro G, Pagani G, Pruneri G (2005) Clinico-prognostic value of D-types cyclins and p27 in laryngeal cancer patients: a review. Acta Otorhinolaryngol Ital 25:75–85
    Pruneri G, Pignataro L, Carboni N, Ronchetti D, Cesana BM, Ottaviani A, Neri A, Buffa R (1998) Clinical relevance of p53 and bcl-2 protein over-expression in laryngeal squamous cell carcinoma. Int J Cancer 79:262–268
    Pruneri G, Pignataro L, Carboni N, Luminari S, Capaccio P, Neri A, Buffa F (1997) MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: association with wild-type p53 accumulation. Mod Pathol 10:785–792
    Qu W, Jiang G, Cruz Y et al (1997) PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35:1304–1310
    Rayburn E, Zhang R, He J, Wang H (2005) MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy. Curr Cancer Drug Targets 5(1):27–41
    Ribeiro KB, Levi JE, Pawlita M, Koifman S, Matos E, Eluf-Neto J, Wunsch-Filho V, Curado MP, Shangina O, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Daudt A, Menezes A, Bencko V, Mates D, Fernandez L, Fabianova E, Gheit T, Tommasino M, Boffetta P, Brennan P, Waterboer T (2011) Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. Int J Epidemiol 40(2):489–502
    Rodrigues RB, Motta RR, Machado SMSM, Cambruzzi R, Zettler EW, Zettler CG, Jotz GP (2008) Prognostic value of the immunohistochemistry correlation of Ki-67 and p53 in squamous cell carcinomas of the larynx. Rev Bras Otorrinolaringol 74(6):855–859
    Sanguinetti CJ, Dias Neto E, Simpson AJ (1994) Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques Natick 17:914–921
    Sanz-Ortega J, Valor C, Saez MC et al (2003) 3p21, 5q21, 9p21 and 17p13 allelic deletions accumulate in the dysplastic spectrum of laryngeal carcinogenesis and precede malignant transformation. Histol Histopathol 18:1053–1057
    Sartor SG, Eluf-Neto J, Travier N, Wunchs Filho V, Arcuri ASA, Kowalski LP, Boffeta P (2007) Occupational risks for laryngeal cancer: a case–control study. Cad Saúde Pública 23(6):1473–1481
    Syrjanen S (2007) Human papillomaviruses in head and neck carcinomas. N Engl J Med 356:1993–1995
    Tamura N, Dong Y, Sui L, Tai Y, Sugimoto K, Nagahata S, Tokuda M (2001) Cyclin-dependent kinase inhibitor p27 is related to cell proliferation and prognosis in laryngeal squamous cell carcinoma. J Laryngol Otol 115:400–406
    Tandon S, Tudur-Smith C, Riley RD, Boyd MT, Jones TM (2011) A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck. Cancer Epidemiol Biomarkers Prev 19(2):574–587
    Tomkova K, Tomka M, Zajac V (2008) Contribution of p53, p63, and p73 to the developmental diseases and cancer. Neoplasma 55(3):177–181
    Torrente MC, Ampuero S, Abud M, Ojeda JM (2005) Molecular detection and typing of human papillomavirus in laryngeal carcinoma specimens. Acta Otolaryngol 125(8):888–893
    Torrente MC, Rodrigo JP, Haigentz M Jr, Dikkers FG, Rinaldo A, Takes RP, Olofsson J, Ferlito A (2011) Human papillomavirus infections in laryngeal cancer. Head Neck 33(4):581–586
    Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408:307–310
    Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cancer worldwide. J Pathol 189:12–19
    Wunchs-Filho V (2004) The epidemiology of laryngeal cancer in Brazil. Sao Paulo Med J 122:188–194
    Yanamoto S, Kawasak G, Yoshitomi I, Mizuno A (2002) p53, mdm2, and p21 expression in oral squamous cell carcinomas: relationship with clinicopathologic factors. Oral Surg Oral Med Oral Pathol 94:593–600
    Yildirim S, Cermik H, Isitmangil T, Baloglu H, Gungor A, Pekkafali Z (2002) Significance of p53 and bcl-2 immunoexpression in the prognosis of laryngeal squamous cell carcinoma. J Int Med Res 30:597–600